“In the United States, 288,300 new cases of prostate cancer are estimated for 20...
The shimmering green, red and purple curtains of the northern and southern light...
CHAPEL HILL, NC — Eating food and absorbing its nutrients is an everyday occurre...
SAN FRANCISCO—December 8, 2023—It only takes holding your breath for slightly to...
Imagine if scientists developed a customizable cancer vaccine that was available...
Tokyo, Japan – Researchers from Tokyo Metropolitan University have measured how ...
SAN DIEGO ― The targeted therapy bezuclastinib was safe and rapidly reduced mark...
Pfizer’s Elrexfio for treating multiple myeloma has been granted conditional ma...
The combination therapy of MSD’s Keytruda (pembrolizumab) and Eisai’s Lenvima (...
Kymera Therapeutics has dosed the first patient in the Phase II ADVANTA trial e...
Vanda Pharmaceuticals has acquired rights to Johnson & Johnson (J&J) company Ac...
The US Food and Drug Administration (FDA) has accepted Alpha Cognition’s new dr...
Clinical-stage radiopharmaceutical company ARTBIO has secured $90m in a Series ...
AbelZeta Pharma and AstraZeneca have signed an agreement to jointly develop...
Vittoria Biotherapeutics will begin in-human studies of its lead chimeric a...
The US Food and Drug Administration (FDA) has accepted Massachusetts-based Next...
